Scientific committee

J. Armitage, M. Björkholm, G. Canellos, P. Carde, F. Cavalli, B. Cheson, T. Chisesi, J. Connors, M. Dietlein, B. Dörken, R. Fisher, A. Gallamini, R. Gascoyne, M. Ghielmini, Th. Girinsky, C. Gisselbrecht, J. Gribben, A. Hagenbeek, R. Hoppe, M. Hutchings, P. Johnson, D. Körholz, R. Küppers, A. Lister, F. Morschhauser, A. Polliack, S. Poppema, J. Raemaekers, A. Rosenwald, N. Schmitz,M. Shipp, L. Specht, H. Stein, A. Sureda, J. Yahalom, A. Younes

Program

The program will be published in due course and will be focused around the following topics.

  • Pathophysiology
  • Early and intermediate Stages
  • Advanced Stages
  • Relapsed or refractory Patients
  • Survivorship
  • HL in Developing Countries
  • HL in Children
  • New Drugs

A second announcement giving a more detailed program together with registration forms, abstract submission details and accommodation details will be available in early 2010.

You may also wish to take a look at the ISHL 2010 Program: 

Printable program (2010 event) at a Glance
in PDF format